Ani Pharmaceuticals reported $86.77M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
Aerie Pharmaceuticals AERI:US $ 51.45M 12.03M
Ani Pharmaceuticals ANIP:US $ 86.77M 3.1M
Aurora Cannabis Inc ACB:CN 1.05B 921.9M
Canopy Growth Corp WEED:CN C$ 1.95B 1.3B
Depomed DEPO:US $ 24.34M 639K
Eli Lilly And LLY:US $ 5277.9M 127.8M
Emergent Biosolutions EBS:US $ 314.7M 13.6M
Heron Therapeutics HRTX:US $ 77.13M 9.25M
Hikma Pharmaceutical HIK:LN 964M 118M
Knight Therapeutics Inc GUD:CN C$ 63.85M 8.85M
Lannett LCI:US $ 100.44M 54.15M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Novartis NVS:US 10.86B 895M
Perrigo Ordinary Shares PRGO:US $ 1137.9M 85.1M
Sun Pharmaceuticals SUNP:IN IR 86110.4M 31485.9M
Teva Pharmaceutical TEVA:IT 4.74B 361M
Teva Pharmaceutical Industries TEVA:US 4.74B 361M